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Abstract
Cannabis use has been found to stimulate appetite and potentially promote weight gain via
activation of the endocannabinoid system. Despite the fact that the onset of cannabis use is
typically during adolescence, the association between adolescence cannabis use and long-
term change in body weight is generally unknown. This study aims to examine the associa-
tion between adolescence cannabis use and weight change to midlife, while accounting for
the use of other substances. The study applied 20 to 22 years of follow-up data on 712 Dan-
ish adolescents aged between 15 and 19 years at baseline. Self-reported height and weight,
cannabis, cigarette and alcohol use, socioeconomic status (SES) and physical activity levels
were assessed in baseline surveys conducted in 1983 and 1985. The follow-up survey was
conducted in 2005. In total 19.1% (n = 136) of adolescents reported having used/using can-
nabis. Weight gain between adolescence and midlife was not related to cannabis exposure
during adolescence in either crude or adjusted models, and associations were not modified
by baseline alcohol intake or smoking. However, cannabis use was significantly associated
with cigarette smoking (p<0.001) and alcohol intake (p<0.001) and inversely associated
with physical activity levels (p = 0.04). In conclusion, this study does not provide evidence of
an association between adolescence cannabis use and weight change from adolescence to
midlife.
Introduction
Cannabis is widely used by younger age groups (15–34 years) [1, 2]. Cannabis use (both
endogenous and exogenous cannabinoids) leads to the activation of the endocannabinoid
system, which modulates the neuronal activity of other neurotransmitters through its action
on the cannabinoid receptors in the brain, more specifically the cannabinoid receptor 1
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(CB1) [3]. This activation stimulates appetite and food intake and hence may promote
weight gain [4]. Despite of the fact that previous studies have found that up to 90% of tetra-
hydrocannabinol (THC, an active ingredient of cannabis) is excreted within 5 days of admin-
istration [5] the effects of THC on brain, especially the morphological changes happening in
the CB1 receptor rich orbitofrontal cortex, seems substantial [6]. The orbitofrontal cortex
has been found to be important in relation to termination of food intake, and the structure
alterations that may occur in cannabis users, may have overconsumption of food as a long-
term effect [7].
The use of cannabis based medicine (dronabino, nabilone and a cannabis extract [THC:
cannabidiol = 1:1]) as an appetite stimulant has been legalized in some states in the United
States (US) and some European countries to treat cancer and HIV related weight loss [8]. The
ability of cannabis to reliably stimulate appetite has led to the development of cannabinoid
receptor antagonists for the treatment of obesity. Four double-blind trials have shown that
daily administration of Rimonabant, a CB1 receptor antagonist, significantly reduced weight
in overweight or obese patients compared with placebo [9–12]. However, Rimonabant was
also found to have psychogenic side effects such as increased anxiety, depression and suicidal-
ity and was removed from the market in Europe, and the application was withdrawn before
the Food and Drug Administration approved it in the US [13].
In recent decades, the effects of cannabis use on body weight have been extensively stud-
ied [14–21]. Although, the onset of cannabis use is typically during adolescence, there has
been little focus on potential effects on weight development of adolescent cannabis use. The
adolescent period is a stage of high neuroplasticity in which the brain undergoes its final
development and maturation [22]. An epigenetic effect of adolescent THC exposure has
been discovered in animal studies that could impact on the expression of genes involved in
brain development. This could ultimately result in alterations of adult brain functioning
and behavior [23]. Hence, exposures to cannabis during developmental periods such as
adolescence may have lead to body weight gain and may result in midlife overweight or
obesity.
Although previous studies in humans have demonstrated an association between canna-
bis use and an increase in appetite and food intake [15, 21], large epidemiological studies
have found conflicting results in relation to weight, with the majority indicating an inverse
association with body weight (Table 1). One of these cross-sectional surveys conducted
among 50,736 US adults aged 18 and over concluded that the prevalence of obesity was
lower among cannabis users than among non-users [14]. Similar findings were reported
by other cross-sectional studies; where current cannabis use was related to a lower Body
Mass Index (BMI) [15–17] and an inverse relationship between BMI and cannabis use in
the past 12 months was found for US women [18]. Conversely, a cross sectional nationally
representative study in the US showed that frequent use of cannabis was associated with
being overweight for 11–14 year old girls, but not in boys [19]. However, one recent longi-
tudinal study among 5,141 adolescents, found that a consistent or increased use of mari-
juana from aged 12 to 18 years was associated with an increased risk of obesity in young
adulthood [20]. On the other hand, another long term prospective study did not find a sig-
nificant relationship between cannabis use and BMI over 15 years in young adults aged 18–
30 years [21].
The aim of the present study was to examine the association between adolescence cannabis
use and weight change from adolescence into midlife. The use of other substances such as
smoking cigarettes and alcohol consumption were also examined as these are likely to modify
the association between cannabis use and adiposity [24, 25].
Cannabis Use in Adolescence and Weight Change
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Method
Data
This study was based on 20 to 22 years of follow-up among 3008 Danish teenagers aged
between 15 and 19, who participated in two surveys conducted in either 1983 or 1985. Via a
questionnaire on lifestyle and sports participation, subjects were asked questions on height
and weight, socioeconomic status (SES), physical activity and substance use including canna-
bis, alcohol and tobacco in both the baseline and the follow-up study.
Of the 3008 participants, 805 could not be contacted at follow-up due to incomplete contact
information, missing linkage information, a request not to be contacted for research purposes,
left Denmark, or had death. Subjects that were traceable (2203 or 73%) were asked to fill out a
mailed follow-up questionnaire. Of these, 786 (36%) returned the questionnaire (Fig 1). Dropout
analysis revealed that age did not differ at follow-up between participants and non-participants
(p = 0.25), but participants had slightly lower mean baseline BMI than non-participants (20.3 vs.
20.6 kg/m2; p = 0.004), and a higher proportion of participants than non-participants were in
the highest SES class (scale 1) (33.9% vs. 26.7%; P = 0.004) [26]. After excluding participants
with incomplete data on BMI information at baseline or follow-up, as well as on cannabis use,
age, alcohol intake, smoking status, physical activity level, SES level, gender at baseline a total of
712 (32% of those traceable) subjects were eligible for inclusion in the present study Fig 1.
The study was conducted in accordance with the Helsinki Declaration. At the baseline data
collection, there was no request for ethical approval, nor was there a consent procedure for
minors. However, at the follow-up study in 2005, all participants provided written informed
consent and approval was obtained from the Danish Data Protection Agency (Journal number:
2015-41-3940), as well as the local ethical committee (The scientific ethical committee for
Copenhagen and Frederiksberg [KF 01-260/04]).
Measures
Exposure. The use of cannabis was assessed with the question “Have you tried cannabis?”
For this question, the participants were given six possible response categories: 1) No (80.9%);
Table 1. Summary of the results from previous studies investigating the association between cannabis use and body weight.
Paper Method/Study
type
Population Outcome Conclusion
[14] Cross-sectional 50,736 adults aged 18 years
or older
Self-reported height and
weight
Inverse association: lower obesity prevalence in cannabis users
[15] Cross-sectional 10,623 adults aged 20–59
years
Measurement of height and
weight were nots specified
Inverse association: current cannabis users had higher caloric
intakes, but slightly lower BMI
[16] Cross-sectional 6281 participants aged 20–59
years
Measured height and weight Inverse association: current cannabis users had significantly
lower BMI and waist circumferences
[17] Cross-sectional 786 adults aged 18–74 years Self-reported height and
weight
Inverse association: cannabis use was statistically associated
with lower BMI
[18] Cross-sectional 297 morbid obesity females
patients aged 16–79 years
Weight and height were
collected from patient charts
Inverse association: higher use of cannabis in women with
lower BMI
[19] Cross-sectional 7825 adolescents aged 11–
17 years
Self-reported height and
weight
Direct association: overweight is associated with cannabis use
in younger girls (aged 11–14), but not boys or girls aged 14–17
years
[20] Longitudinal 5,141 adolescents aged from
12–18 years
Self-reported height and
weight
Direct association: consistent or increased patterns of
marijuana use in adolescence are associated with an increased
risk of obesity
[21] 15 years
longitudinal
3,617 young adults aged from
18–30 years
Measured height and weight No association: no relationship between the use of cannabis
and BMI
doi:10.1371/journal.pone.0168897.t001
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2) Yes, but only once (5.3%); 3) Yes, a few times (7.0%); 4) Yes, but I have stopped (1.7%); 5)
Yes, I still smoke once in a while (4.4%); 6) Yes, I smoke often (0.7%). Due to the small per-
centage of the participants who reported regular use of cannabis (0.7%) in comparison to
those who reported no use (80.9%), we classified respondents who answered no as abstainers
while the remaining were considered users (e.g. current or previous users of cannabis once or
more). Supplementary analysis was also performed by grouping cannabis intake into three
groups:abstainers (who answered no in the questionnaire), experimenters (who answered Yes,
but only once and Yes, a few times) and frequent users (who answered Yes, but stopped, Yes, and
I still smoke occasionally and Yes, and I still smoke regularly.) (S1 Table).
Outcome. BMI was calculated using self-reported height and weight for both baseline and
follow-up surveys. Differences in BMI between baseline and follow-up were calculated as a
continuous variable. BMI25.0kg/m2 was defined as overweight.
Covariates. Alcohol consumption was assessed by the question “How often do you drink
different types of alcohol?” with three choices—beer, wine and spirit. The following assump-
tions were made to quantify the amount of alcohol consumption according to the possible
answers to the question: 1) Never– 0 standard drink per week; 2) Very rarely– 0.08 (1/12) stan-
dard drink per week; 3) Once a month– 0.25 standard drink per week; 4) Twice per month–
Fig 1. Study population flow chart. Fig 1 provides information on the participants flow between the baseline
and follow-up surveys.
doi:10.1371/journal.pone.0168897.g001
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0.5 standard drink per week; 5) Once a week– 1 standard drink per week; 6) 2–3 times per
week—2.5 standards drink per week; 7) everyday– 7 standard drinks per week. All drinks were
assumed to be standard drinks, and were calculated as units per week, and summed to create
total alcohol consumption.
Smoking was assessed with the question “Do you smoke?” and responses categorised into
smokers and non-smokers.
Participants were asked to report parental occupation and the highest education at the time
when the participants were 10–12 years old. Those, with> 4yr of further education (master
level), white-collar workers with> 50 subordinates, and self-employed with >20 employees
were placed in SES group 1. Persons with short or medium further education (up to 4yr),
white-collar workers with 11–50 subordinates (if no master level education), and self-
employed with 6–20 employees (if no master level education) were placed in SES group 2. Per-
sons with short education (up to 1yr), vocational education, white-collar workers with 1–10
subordinates (if no education corresponding to SES group 1 or 2), and self-employed with 0–5
employees (if no education corresponding to SES group 1 or 2) were placed in SES group 3.
Skilled workers and white-collar workers with no subordinates (if no education corresponding
to SES group 1, 2, or 3) were placed in SES group 4. Semiskilled and unskilled workers were
placed in SES group 5 [27]. The two highest SES groups (1 and 2) were collapsed and labeled
‘high SES’, SES group 3 was labeled ‘medium SES’ and the two lowest SES groups (4 and 5)
were collapsed and labeled ‘low SES’. SES at baseline was based on paternal SES. If no SES
could be assigned to the father, maternal SES was used.
Subjects were asked for the different types of the sports they pursued at school and the
number of hours per week spent on each sport. Leisure time physical activity was assessed by
questionnaire, where participants filled in the different types of sports clubs they attended and
the time they actively participated in each type of sport per week. Lastly, the type and the
amount of time spend on activities outside of school and sports clubs were also assessed. Each
sport and activity was translated into a metabolic equivalent (MET) scores [28]. Total energy
expenditure from all activities was calculated for each participant.
Statistical analysis
Descriptive analyses for the cohorts’ characteristics were conducted according to cannabis use,
and tested using independent unpaired t-test for continuous variables and chi-square test for
categorical variables. To estimate the association between cannabis use and changes in BMI,
univariate generalized linear models were used, followed by stratification of the sample by gen-
der and baseline smoking status. Crude estimation of associations was identified first, and
potential covariates were adjusted for in subsequent models. Baseline covariates included
smoking, alcohol intake, BMI, SES and physical activity levels. Effect modification was exam-
ined with respect to gender, age, BMI, smoking and alcohol use during adolescence by testing
for the interactions with cannabis use in relation to adult BMI. As a sensitivity test, a logistic
regression model with adult overweight (BMI25.0kg/m2) as categorical outcome was fitted
with the exposure to cannabis. Results were considered significant when p<0.05 (two-sided).
SPSS Statistics version 21 was used for all analyses.
Results
Participant characteristics
Characteristics of the participants are given in Table 2. Of the 712 eligible participants, 136
(19.1%) reported use of cannabis during adolescence. Cannabis use at baseline was associated
with cigarette smoking (p<0.001), and alcohol intake (p<0.001) irrespective of the type of
Cannabis Use in Adolescence and Weight Change
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alcohol. Cannabis use was inversely associated with baseline physical activity (p = 0.04). Gen-
der, baseline BMI, and SES levels were not related to cannabis use.
Cannabis use in adolescence and subsequent changes in BMI
There were no significant differences in the changes in BMI from adolescence to midlife
between cannabis abstainers and cannabis users in the crude model (Table 3), and results were
essentially similar after adjusting for baseline gender, baseline BMI, age, SES, physical activity,
smoking status and alcohol consumption. The changes in BMI were also similar for cannabis
abstainers and cannabis users after stratifying the sample by alcohol intake (Table 4). When
stratifying the sample by smoking status, those who did not smoke but used cannabis had the
Table 2. Participant characteristics according to cannabis use at baseline.
Characteristics Cannabis Abstainers Cannabis Exposures p-value^
n = 576 n = 136
Mean ± SEM Age baseline (years) 16.9 ± 0.04 17.2 ± 0.09 0.002
BMI (kg/m2) Baseline 20.3 ± 0.09 20.5 ± 0.17 0.42
BMI (kg/m2) Follow-up 24.4 ± 0.16 24.4 ± 0.30 0.55
Total alcohol intake baseline (drinks/week) 1.32 ± 0.06 2.60 ± 0.18 <0.001
Beer 0.64± 0.04 1.44 ± 0.12 <0.001
Wine 0.44 ±0.03 0.73 ± 0.08 0.001
Spirit 0.31 ± 0.02 0.58 ± 0.06 <0.001
Physical Activity (in MET score) 5.37 ± 0.30 4.00 ± 0.43 0.04
Gender (%) - - 0.36
Male 41.8 37.5
Female 58.2 62.5
SES (%) - - 0.19
High 32.3 40.4
Medium 29.0 25.0
Low 38.7 34.6
Smoking (%) - - <0.001
Non-smoker 86.3 43.4
Smoker 13.7 56.6
^ Independent t-test for continuous variables and chi-square tests for trend for categorical variables across cannabis use.
doi:10.1371/journal.pone.0168897.t002
Table 3. Mean changes in BMI (95%CI) (kg/m2) between adolescence and midlife according to baseline cannabis use.
Abstainers Exposures p-value
(n = 576) (n = 136)
Crude 4.1 (3.8, 4.4) 3.7 (3.2, 4.3) 0.22
Adjusted for SES baseline 4.1 (3.8, 4.4) 3.7 (3.2, 4.3) 0.26
Adjusted for gender 4.1 (3.8, 4.4) 3.8 (3.2, 4.3) 0.28
Adjusted for Physical Activity baseline 4.1 (3.8, 4.4) 3.7 (3.1, 4.2) 0.17
Adjusted for BMI baseline 4.1 (3.8, 4.4) 3.7 (3.2, 4.3) 0.24
Adjusted for baseline alcohol intake 4.1 (3.8, 4.3) 3.8 (3.3, 4.4) 0.46
Adjusted for baseline smoking status 4.1 (3.8, 4.4) 3.7 (3.1, 4.3) 0.21
Adjusted for baseline age 4.1 (3.8, 4.4) 3.8 (3.2, 4.3) 0.36
Adjusted for all 4.1 (3.8, 4.3) 3.9 (3.3, 4.5) 0.55
doi:10.1371/journal.pone.0168897.t003
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smallest numerical change in BMI of 3.5 kg/m2, while those who were both cigarette and can-
nabis free had the greatest numerical change in BMI of 4.1kg/m2 but these differences were
not significant in any of the models (Table 5). There also were no differences in the odds ratios
for overweight/obesity (BMI 25 kg/m2) between cannabis abstainers and users in the logistic
regression analyses (results not shown). As a supplementary test, we grouped cannabis use
into abstainers, experimenters and frequent users, and performed univariate and adjusted
logistic regression analysis (S2 Table). Consistent with our previous analyses, no differences in
weight gain between groups were detected. Finally, we compared the mean changes in BMI
between cannabis abstainers at both baseline and follow-up, to those who reported using can-
nabis at both surveys (Table 6). Again, the results revealed no association between cannabis
use and changes in BMI.
Discussion
Our study suggests that use of cannabis in adolescence was not related to long-term weight
change in midlife.
The lack of association between cannabis use in adolescence and development of obesity in
midlife could be explained by two main perspectives; indirect social process as well as biologi-
cal reactions. First, Marijuana use, especially heavy use, may indicate membership in a social
Table 4. Mean changes in BMI (95%CI) (kg/m2) between adolescence and midlife in stratified model by baseline alcohol intake according to base-
line cannabis use.
Cannabis Use Low Alcohol Intake (25th Percentile) Moderate Alcohol Intake High Alcohol Intake (75th Percentile)
Crude Abstainers 4.3 (3.9, 4.8) 4.1 (3.7, 4.6) 3.7 (3.2, 4.2)
n = 228 n = 195 n = 153
Exposures 3.3(1.6, 5.0) 4.1 (3.2, 5.1) 3.6 (2.9, 4.3)
n = 17 n = 39 n = 80
P-value$ 0.24 0.99 0.80
Adjusted# Abstainers 4.3 (3.8, 4.8) 4.2 (3.8, 4.6) 3.7 (3.2, 4.2)
Exposures 3.7 (1.9, 5.6) 3.8 (2.9, 4.9) 3.7 (2.9, 4.4)
P-value$ 0.57 0.54 0.96
# Adjusted for gender, BMI, age, physical activity, smoking and SES status at baseline.
$ p-values for differences between abstainers and exposures.
doi:10.1371/journal.pone.0168897.t004
Table 5. Means changes in BMI (95%CI) (kg/m2) between adolescence and midlife in stratified model by baseline smoking status according to
baseline cannabis use.
Cannabis Use Smokers Non-smokers
Crude Abstainers 4.1 (3.4, 4.8) 4.1 (3.8, 4.4)
n = 79 n = 497
Exposures 3.9 (3.1, 4.6) 3.5 (2.7, 4.3)
n = 77 n = 59
P-value$ 0.70 0.18
Adjusted# Abstainers 4.1 (3.3, 4.8) 4.1 (3.8, 4.4)
Exposures 3.9 (3.2, 4.7) 3.8 (2.9, 4.6)
P-value$ 0.81 0.52
# Adjusted for gender, BMI, age, alcohol consumption, physical activity and SES status at baseline.
$ p-values for differences between abstainers and exposures.
doi:10.1371/journal.pone.0168897.t005
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group whose weight-related norms act to suppress weight. It has been reported that marijuana
use might be linked to unhealthy weight loss practices in adolescence such as 24h fasting,
use of diet pills use or laxative use/purging [29]. Moreover, there is a substantial possibility for
confounding because of the long interval between adolescence and mid-life that may be stron-
ger than potential programming effects from adolescent cannabis exposure, and may explain
why we did not see significant associations with long-term development in weight gain.
Second, the potential cannabis effects on increase of appetite could be outweighed by a
higher metabolic rate among cannabis users [30], and resulting in the lack of association
between cannabis use and weight gain observed in the present study. A previous small placebo-
controlled study showed that smoking cannabis caused a 28% increase in the metabolic rate
[30]. A higher metabolic rate in cannabis users might also be the reason why those with canna-
bis exposures had a similar BMI as cannabis abstainers even if they had significantly lower
physical activity levels. Tetrahydrocannabivarin (THCV), an active ingredient in cannabis, has
been shown to produces weight loss, decreased body fat and serum leptin concentrations with
increased energy expenditure properties in animals [31, 32]. Therefore, this anti-obesity activity
of THCV could have diminished the appetite stimulating function of THC’s [8].
In our study, although there was no statistical significant difference in BMI between
abstainers and users, adolescents who used cannabis were less physically active than those who
did not use it. It is possible that cannabis users are less motivated for doing exercise. In support
of this, a previous study found that smoking cannabis caused morphological changes in orbital
frontal cortex [7] which is involved in motivation [33].
Smoking is an important confounder in the association between the cannabis use and
weight change as smoking is related to both body weight status [34, 35] and to cannabis use.
Smoking hashish is the most frequent form of cannabis consumption in Denmark, and hashish
is frequently mixed with tobacco when used. However, results obtained after adjustment for
smoking were essentially similar to those obtained from the crude analysis. Furthermore, can-
nabis users also had higher alcohol consumption. However, as with smoking, there was no evi-
dence that our results were dependent on differences in alcohol intake between users and non-
users of cannabis, or that the association between cannabis use and long-term weight change
was modified by alcohol intake.
The present study advances the field in several ways. First, our study used longitudinal data
focusing on adolescence cannabis use and weight changes, which is an advance since most pre-
vious studies were cross sectional [14–19]. Moreover, majority of previous studies did not con-
sider simultaneous use of other substances such as tobacco or alcohol intake [16–18, 20].
However, the study results must also be interpreted with care due to some limitations. First,
Table 6. The mean changes in BMI (95%CI) (kg/m2) between adolescence and midlife according to cannabis abstinence or exposure at both base-
line and follow-up.
Changes in BMI (95%CI) Abstainer at baseline and Abstainer
at follow-up
Exposure at baseline and Exposure
at follow-up
P value for the differences in
group mean
n = 360 n = 124
Crude 4.2 (3.8, 4.5) 3.9 (3.3, 4.5) 0.43
Adjusted for confounders at
baselinea
4.2 (3.8, 4.6) 3.9 (3.2, 4.6) 0.51
Adjusted for confounders at
follow-upb
4.1 (3.9, 4.3) 4.2 (3.8, 4.6) 0.64
a Adjusted for gender, BMI, age, alcohol consumption, physical activity, smoking and SES status at baseline.
b Adjusted for gender, BMI, age, alcohol consumption, physical activity, smoking and SES status at follow-up.
doi:10.1371/journal.pone.0168897.t006
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cannabis use and BMI data were self-reported and may be biased. People generally tend to
underestimate the actual usage of drugs as well as underreport their body weight while over-
reporting their height [36]. Such reporting bias would tend to mask a true direct relation link-
ing cannabis use to long-term risk of overweight and obesity, while it would tend to inflate a
true inverse relation between cannabis and long term risk of overweight and obesity. Second,
effects of cannabis use may be dependent on duration of usage, and the possible answers
related to cannabis use, lacked the desired amount of details such as duration of usage. This
may have led to an attenuation of our results. Third, the dropout from baseline to follow-up
was large. It has been reported that dropout rates are often higher in the lower SES groups, as
well as in the obese/diseased individuals compared with higher SES groups and normal-weight
people [37]. The large drop-out rate also resulted in small sample size in our study. In addition
to the small sample size, the distributions between measurements groups of cannabis were
skewed. Despite the lack of statistical association between cannabis use and obesity, the
numerical data agrees with the results of two US national cross-sectional studies, indicating an
inverse rather than a direct association between cannabis use and obesity [14, 15]. This was
also the case in the present study, where mean baseline BMI was higher in the group that did
not participate in the follow-up survey compared to those who participated. Therefore, the sta-
tistical association could have been biased due to greater drop-out in low SES and high BMI
individuals. Lastly, information on dietary intake, which is one of the major factors affecting
body weight, was not available and hence could not be adjusted for in the present analyses.
Apart from these biological factors, also social factors may have indirectly affected the associa-
tion between cannabis use and body weight. Although, SES was a covariate in the analyses, it is
only one measure of social factors. Hence, residual confounding is likely.
Conclusion
This study did not find support that adolescent use of cannabis was related to subsequent
weight change into midlife.
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